That last agreement cut the portfolio of own or leased hospitals from 75, which have a license bed count of approximately 11,000. When the signed and contemplated agreements are completed, the company’s holdings will be approximately one third of the size of what were a decade ago, which was a year after buying health management associates.
Then, the CHS portfolio was in 205 hospitals that house approximately 31,000 licensed beds. But debt struggles and operational struggles of the company’s $ 19 billion in some of the HMA acquired facilities led executives to launch an important divestment program. Recent sales are a consequence of this initiative promoted by the left of the long -term debt of CHS: the company ended 2024 with $ 11.4 billion of pending debt and a shareholders’ deficit of almost $ 1.7 billion.
Hingtgen said on February 19 that his team’s broad plan, sales sales outside of what the central markets consider and invest in the expansion of the network in key regions (such as the acquisition of 10 urgent care centers in Arizona), is paying off. CHS has a series of surgery center constructions or aligned expansions, he said, and is advancing with several independent emergency departments. Executives also seek to make their subsequent and behavioral health service lines grow more.
«It is a smaller wallet that generates approximately [a] Similar amount of net income three or four years ago, ”said Hingtgen. «We know that our investments are producing the planned results, taking care of more patients and promoting that type of growth.»
CHS published a fourth quarter Net loss of $ 70 million in almost $ 3.3 billion in operational revenues. At the end of 2023, these numbers were a gain of $ 46 million and approximately $ 3.2 billion, respectively. The Ebitda adjusted for the quarter increased 11% year after year to $ 428 million, while the net cash of the operations doubled to $ 216 million.
CHS actions (Ticker: Cyh) Increased more than 7 percent in that earnings report to $ 3.61 each. However, more than 25 percent have still dropped in the last six months, mainly due to a fall after executives reported results of the third quarter that were affected by a growing number of claims denials. The company’s market capitalization is now around $ 490 million.
